搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Gossypium hirsutum ATP synthase subunit alpha, chloroplastic (atpA), partial CSB-YP641672GHB
CSB-EP641672GHB
CSB-BP641672GHB
CSB-MP641672GHB
CSB-EP641672GHB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gossypium hirsutum DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP641673GHB
CSB-EP641673GHB
CSB-BP641673GHB
CSB-MP641673GHB
CSB-EP641673GHB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gossypium hirsutum Photosystem I P700 chlorophyll a apoprotein A1 (psaA), partial CSB-YP641674GHB
CSB-EP641674GHB
CSB-BP641674GHB
CSB-MP641674GHB
CSB-EP641674GHB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gossypium hirsutum Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta, chloroplastic (accD) CSB-YP641675GHB
CSB-EP641675GHB
CSB-BP641675GHB
CSB-MP641675GHB
CSB-EP641675GHB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gossypium hirsutum Cytochrome b6-f complex subunit 6 (petL), partial CSB-YP641676GHB
CSB-EP641676GHB
CSB-BP641676GHB
CSB-MP641676GHB
CSB-EP641676GHB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gossypium hirsutum Photosystem II CP47 chlorophyll apoprotein (psbB), partial CSB-YP641677GHB1
CSB-EP641677GHB1
CSB-BP641677GHB1
CSB-MP641677GHB1
CSB-EP641677GHB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gossypium hirsutum 50S ribosomal protein L16, chloroplastic (rpl16) CSB-YP641678GHB
CSB-EP641678GHB
CSB-BP641678GHB
CSB-MP641678GHB
CSB-EP641678GHB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gossypium hirsutum Protein ycf2 (ycf2-A), partial CSB-YP641679GHB
CSB-EP641679GHB
CSB-BP641679GHB
CSB-MP641679GHB
CSB-EP641679GHB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gossypium hirsutum NAD (P)H-quinone oxidoreductase subunit 6, chloroplastic (ndhG), partial CSB-YP641680GHB1
CSB-EP641680GHB1
CSB-BP641680GHB1
CSB-MP641680GHB1
CSB-EP641680GHB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lynx lynx Steroid 21-hydroxylase (CYP21) CSB-YP641681LLA
CSB-EP641681LLA
CSB-BP641681LLA
CSB-MP641681LLA
CSB-EP641681LLA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium citrinum Ribosomal protein S8, mitochondrial (mrps8) CSB-YP641682DDU
CSB-EP641682DDU
CSB-BP641682DDU
CSB-MP641682DDU
CSB-EP641682DDU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium citrinum Cytochrome c oxidase subunit 3 (cox3), partial CSB-YP641683DDU1
CSB-EP641683DDU1
CSB-BP641683DDU1
CSB-MP641683DDU1
CSB-EP641683DDU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium citrinum NADH-ubiquinone oxidoreductase chain 6 (nad6), partial CSB-YP641684DDU1
CSB-EP641684DDU1
CSB-BP641684DDU1
CSB-MP641684DDU1
CSB-EP641684DDU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Acrosome formation-associated factor (Afaf), partial CSB-YP641685RA
CSB-EP641685RA
CSB-BP641685RA
CSB-MP641685RA
CSB-EP641685RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xenopus laevis BTB/POZ domain-containing protein 6 (btbd6), partial CSB-YP641686XBE
CSB-EP641686XBE
CSB-BP641686XBE
CSB-MP641686XBE
CSB-EP641686XBE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Toll-interacting protein (TOLLIP) CSB-YP641687BO
CSB-EP641687BO
CSB-BP641687BO
CSB-MP641687BO
CSB-EP641687BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chicken Protein Wnt-3a (WNT3A) CSB-YP641688CH
CSB-EP641688CH
CSB-BP641688CH
CSB-MP641688CH
CSB-EP641688CH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Syntrophus aciditrophicus Guanylate kinase (gmk) CSB-YP641689SAAZ
CSB-EP641689SAAZ
CSB-BP641689SAAZ
CSB-MP641689SAAZ
CSB-EP641689SAAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Syntrophus aciditrophicus 50S ribosomal protein L10 (rplJ) CSB-YP641690SAAZ
CSB-EP641690SAAZ
CSB-BP641690SAAZ
CSB-MP641690SAAZ
CSB-EP641690SAAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Syntrophus aciditrophicus 50S ribosomal protein L23 (rplW) CSB-YP641691SAAZ
CSB-EP641691SAAZ
CSB-BP641691SAAZ
CSB-MP641691SAAZ
CSB-EP641691SAAZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>